Abstract:Background: An imbalance in the redox homeostasis has been reported in multiple cancers and is associated with a poor prognosis of disease. However, the prognostic value of redox-related genes in non-small-cell lung cancer (NSCLC) remains unclear. Methods: RNA sequencing data, DNA methylation data, mutation, and clinical data of NSCLC patients were downloaded from The Cancer Genome Atlas and Gene Expression Omnibus databases. Redox-related differentially expressed genes (DEGs) were used to construct the prognostic signature using least absolute shrinkage and selection operator (LASSO) regression analysis. Kaplan–Meier survival curve and receiver operator characteristic (ROC) curve analyses were applied to validate the accuracy of the gene signature. Nomogram and calibration plots of the nomogram were constructed to predict prognosis. Pathway analysis was performed using gene set enrichment analysis. The correlations of risk score with tumor stage, immune infiltration, DNA methylation, tumor mutation burden (TMB), and chemotherapy sensitivity were evaluated. The prognostic signature was validated using GSE31210, GSE26939, and GSE68465 datasets. Real-time polymerase chain reaction (PCR) was used to validate dysregulated genes in NSCLC. Results: A prognostic signature was constructed using the LASSO regression analysis and was represented as a risk score. The high-risk group was significantly correlated with worse overall survival (OS) ( p < 0.001). The area under the ROC curve (AUC) at the 5-year stage was 0.657. The risk score was precisely correlated with the tumor stage and was an independent prognostic factor for NSCLC. The constructed nomogram accurately predicted the OS of patients after 1-, 3-, and 5-year periods. DNA replication, cell cycle, and ECM receptor interaction were the main pathways enriched in the high-risk group. In addition, the high-risk score was correlated with higher TMB, lower methylation levels, increased infiltrating macrophages, activated memory CD4 + T cells, and a higher sensitivity to chemotherapy. The signature was validated in GSE31210, GSE26939, and GSE68465 datasets. Real-time PCR validated dysregulated mRNA expression levels in NSCLC. Conclusions: A prognostic redox-related gene signature was successfully established in NSCLC, with potential applications in the clinical setting.

A reactive oxygen species-related signature predicts the prognosis and immunosuppressive microenvironment in gliomas

A Prognostic Risk Model of a Novel Oxidative Stress-Related Signature Predicts Clinical Prognosis and Demonstrates Immune Relevancy in Lung Adenocarcinoma.

The Significance of the Redox Gene in the Prognosis and Therapeutic Response of Glioma

Discovery of a Novel ROS-based Signature for Predicting Prognosis and Immunosuppressive Tumor Microenvironment in Lung Adenocarcinoma

Reactive Oxygen Species Regulate T Cell Immune Response in the Tumor Microenvironment

Glutathione metabolism-related gene signature predicts prognosis and treatment response in low-grade glioma

Multifaceted role of redox pattern in the tumor immune microenvironment regarding autophagy and apoptosis

The Role of Redox Environment in Tumors

Thioredoxin Activity Confers Resistance Against Oxidative Stress In Tumor-Infiltrating Nk Cells

ROS regulation in gliomas: implications for treatment strategies

Identification of a Novel Oxidative Stress- and Anoikis-Related Prognostic Signature and Its Immune Landscape Analysis in Non-Small Cell Lung Cancer

Redox Regulator <i>GLRX</i> Is Associated With Tumor Immunity in Glioma

Potential targets and treatments affect oxidative stress in gliomas: An overview of molecular mechanisms

Reactive Oxygen Species Bridge the Gap between Chronic Inflammation and Tumor Development

Antioxidant network-based signatures cluster glioblastoma into distinct redox-resistant phenotypes

Function of reactive oxygen species in myeloid-derived suppressor cells

Identification of the Signature Genes and Network of Reactive Oxygen Species Related Genes and DNA Repair Genes in Lung Adenocarcinoma

Construction of a redox-related gene signature for overall survival prediction and immune infiltration in non-small-cell lung cancer

An Oxidative Stress-Related Prognostic Signature for Indicating the Immune Status of Oral Squamous Cell Carcinoma and Guiding Clinical Treatment

Reactive Oxygen Species in Anticancer Immunity: A Double-Edged Sword

Identification of a novel reactive oxygen species (ROS)-related genes model combined with RT-qPCR experiments for prognosis and immunotherapy in gastric cancer